rent-now

Rent More, Save More! Use code: ECRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

9780721634838

Pharmacology and Therapeutics in Respiratory Care

by ;
  • ISBN13:

    9780721634838

  • ISBN10:

    0721634834

  • Format: Hardcover
  • Copyright: 1994-01-01
  • Publisher: W B Saunders Co
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $54.00

Summary

PHARMACOLOGY AND THERAPEUTICS IN RESPIRATORY CARE is designed primarily for undergraduate respiratory care students and practicing clinicians. The text is divided into three sections which will discuss the scientific basis for therapy, drug classes used in respiratory care, and topical and practical therapeutic and research issues that are overlooked in most respiratory care textbooks.

Table of Contents

PART I SCIENTIFIC BASIS FOR THERAPY 1(135)
Basic Drug Science Applied to Respiratory Care
3(28)
Pharmacokinetics
3(12)
Administration and Absorption
4(1)
Drug Transfer Across Membranes
4(3)
Bioavailability
7(1)
Distribution, Clearance, and Half-Life
8(4)
Biotransformation and Elimination
12(3)
Pharmacodynamics
15(6)
Receptors and Post-Receptor Events
15(1)
Receptors and Their Subtypes
15(2)
Quantifying Interactions Between Drug and Receptor
17(2)
Agonists
19(1)
Antagonists
19(2)
Pharmacotherapy
21(10)
The Scientific Basis for Inhalation Therapy
21(1)
Delivery
21(1)
Treating the Patient as a Unique Individual
22(1)
Regulation and Development of Drugs
22(5)
Sources of Information about Drugs
27(4)
Delivery of Drugs by Aerosol
31(26)
Definition and Description of Aerosols
32(1)
General Factors Affecting Aerosol Deposition
33(1)
Generation and Delivery of Aerosols
34(12)
Small Volume Nebulizers
34(3)
Ultrasonic Nebulizers
37(2)
Metered Dose Inhalers
39(5)
Dry Powder Inhalers
44(2)
Other Delivery Methods
46(1)
Selection of an Aerosol Delivery Device
46(3)
Financial Considerations
48(1)
Special Considerations in Aerosol Therapy
49(8)
Aerosol Delivery During Mechanical Ventilation
49(1)
Nasal Delivery of Aerosols
49(1)
Occupational Safety and Health
50(1)
Environmental Issues
51(6)
Pulmonary Smooth Muscle
57(30)
Contractile Tissue
58(3)
Description of Smooth Muscle
61(2)
Cellular Energetics Associated with Smooth Muscle Activity
63(2)
Activation of Smooth Muscle
65(1)
Autonomic Control of the Airway
65(7)
Parasympathetic Innervation
65(2)
Sympathetic Innervation
67(3)
Nonadrenergic Noncholinergic Innervation
70(2)
Other Modulators of Smooth Muscle Tone
72(5)
Prostaglandins
72(2)
Histamine
74(1)
Serotonin
74(1)
Leukotrienes
75(1)
Bradykinin
75(1)
Platelet Activating Factor
75(1)
Carbon Dioxide and pH
76(1)
Oxygen
76(1)
Temperature
76(1)
Airway Smooth Muscle and Bronchial Hyperresponsiveness
77(2)
Pulmonary Vascular Smooth Muscle
79(2)
Summary
81(6)
Mucus and Its Clearance in Health and Disease
87(22)
Basic Physiology of Mucus, Cilia, and Cough
88(9)
Mucus
88(5)
Cilia and Mucociliary Clearance
93(2)
Cough
95(2)
Abnormalities in Mucus, Cilia, and Cough
97(3)
Abnormal Mucous Secretion
97(1)
Abnormal Ciliary Function
97(1)
Persistent Cough
97(3)
Mucociliary Clearance and Cough: Clinical Observations
100(1)
Asthma
100(1)
Chronic Bronchitis and Emphysema
100(1)
Bronchiectasis
100(1)
Cystic Fibrosis
101(1)
Carcinoma of the Lung
101(1)
Tuberculosis
101(1)
Rhinitis
101(1)
Clinical Characteristics of Airway Secretion
101(8)
Macroscopic Characteristics
102(1)
Microscopic Characteristics
103(6)
Airway Immunology in Health and Disease
109(26)
Immune Responses
109(16)
Nonspecific Immune Responses
110(3)
Specific Immune Responses
113(1)
Humoral Responses
114(5)
Antibody Structure and Classes of Immunoglobulin
119(3)
Functional Roles of Antibodies
122(1)
Complement System
122(2)
Cell-Mediated Immunity
124(1)
Immunologic Deficiency and Hypersensitivity Diseases
125(5)
Immunologic Deficiency Diseases
125(2)
Diseases Due to Altered Immune Function
127(3)
Immunologic Testing for Disease
130(1)
Summary
131(4)
PART II RESPIRATORY CARE DRUGS 135(216)
Adrenergic Agents
137(30)
Adrenergic Pharmacology
138(6)
The Autonomic Nervous System
138(1)
Adrenergic Receptors
139(3)
Second Messengers and Intracellular Events
142(2)
Adrenergic Agonists: The Relation Between Structure and Activity
144(4)
Structure and Function of Sympathomimetic Amines
144(4)
Uptake and Metabolism of Sympathomimetic Amines
148(1)
Effects of Adrenergic Agonists
148(6)
General Effects on the Airway
148(1)
Effects Outside of the Airway
149(5)
The Clinical Utility of Adrenergic Agonists
154(3)
Bronchodilators
154(2)
Nasal Decongestants
156(1)
Specific Adrenergic Agents
157(10)
Beta-Adrenergic Bronchodilators
157(5)
Alpha-Adrenergic Nasal Decongestants
162(5)
Antimuscarinic Drugs
167(16)
Muscarinic Pharmacology
168(4)
Nicotinic Versus Muscarinic Action of Acetylcholine
168(1)
Muscarinic Innervation
168(1)
Muscarinic Receptors
168(1)
Subtypes of Muscarinic Receptor
169(2)
Post-Receptor Events
171(1)
Effects of Antimuscarinic Drugs
172(2)
General Effects on the Airway
172(1)
Other Effects
173(1)
Use of Antimuscarinic Drugs
174(4)
Asthma
174(1)
Chronic Bronchitis and Emphysema
175(2)
Differences in Asthma and Chronic Obstructive Pulmonary Disease
177(1)
Rhinitis
177(1)
Antimuscarinic Agents
178(5)
Chemistry
178(1)
Pharmacokinetics
179(1)
Method of Administration
179(1)
Tolerance
179(1)
Safety and Side Effects
179(4)
Theophylline and Other Methylxanthines
183(24)
Sources, Chemistry, and Preparations
184(1)
Mechanisms of Action
185(6)
Phosphodiesterase Inhibition
187(2)
Adenosine Antagonism
189(1)
Enhanced Release of Catecholamines
190(1)
Prostaglandin Inhibition
190(1)
Pharmacologic Effects in the Respiratory System and Treatment of Obstructive Lung Disease
191(2)
Nocturnal Symptoms of Asthma
191(1)
Mucociliary Function
192(1)
Enhancement of Diaphragmatic Function
192(1)
Treatment of Asthma
192(1)
Treatment of Chronic Obstructive Pulmonary Disease
193(1)
Other Pharmacologic Effects of Methylxanthines
193(2)
Central Nervous System
193(1)
Cardiovascular System
194(1)
Renal System
194(1)
Skeletal Muscle
194(1)
Gastric Mucosa and Muscle Tone of the Esophageal Sphincter
194(1)
Pharmacokinetics of Theophylline
195(6)
Absorption
195(1)
Distribution
195(2)
Metabolism and Elimination
197(2)
Clinical Use: Dose and Route of Administration
199(2)
Adverse Reactions and Overdose
201(2)
Summary
203(4)
Corticosteroids
207(32)
Corticosteroids and the Adrenal Glands
208(2)
Structure and Metabolism of Corticosteroids
210(2)
Mechanisms of Action of Glucocorticoids
212(2)
Physiologic and Pharmacologic Effects of Glucocorticoids
214(4)
Intermediate Metabolism
214(1)
Water and Electrolyte Balance
215(1)
Gastrointestinal Tract
215(1)
Cardiovascular Function
215(1)
Central Nervous System
215(1)
Endocrine System
216(1)
Anti-Inflammatory and Anti-Immunologic Properties of Glucocorticoids
216(1)
Release of Mediators
216(1)
Interaction Between Glucocorticoids and β-Adrenergic Receptors
217(1)
Vascular Permeability
217(1)
Clinical Indications for the Use of Glucocorticoids to Treat Lung Disease
218(2)
Obstructive Airway Diseases
218(1)
Other Pulmonary Conditions
219(1)
Adverse Effects of Glucocorticoids
220(2)
Osteoporosis and Glucocorticoids
222(3)
Administration of Glucocorticoids
225(1)
Refractoriness to Glucocorticoids in the Treatment of Asthma
226(1)
Topical Glucocorticoids in the Management of Airway Disease
226(1)
Nonsteroidal Strategies to Reduce Glucocorticoid Dependence
227(2)
Troleandomycin
227(1)
Cytotoxic Agents
228(1)
Glucocorticoid Drugs
229(6)
Hydrocortisone
229(1)
Cortisone
229(3)
Prednisone
232(1)
Prednisolone
232(1)
Methylpredinsolone
232(1)
Dexamethasone
232(1)
Triamcinolone
233(1)
Beclomethasone Dipropionate
233(1)
Betamethasone
234(1)
Flunisolide
234(1)
Budesonide
234(1)
Fluticasone
235(1)
Summary
235(4)
Agents That Affect Mucus and Cough
239(20)
Agents That Affect Mucus
240(7)
Hydrating Agents and Diluents: Bland Aerosols
240(1)
Expectorants
241(3)
Mucolytics
244(2)
Secondary Mucokinetic Drugs
246(1)
Agents That Inhibit Cough
247(12)
Centrally Acting Drugs
247(3)
Other Centrally Acting Agents
250(1)
Local Anesthetics
251(1)
Aromatics and Aromatic Mixtures
252(1)
Secondary Antitussive Agents
252(7)
Antihistamines and Other Mediator Modifying Drugs
259(30)
H1-Receptor Antagonists
260(11)
Chemistry
260(1)
Pharmacologic Properties
260(3)
Pharmacokinetics
263(2)
Clinical Use
265(1)
Individual Agents
266(5)
Mediator Modifying Compounds
271(5)
Sodium Cromoglycate
271(4)
Nedocromil
275(1)
Ketotifen
275(1)
Specific Mediators and Their Antagonists
276(5)
Leukotrienes
276(3)
Prostaglandins
279(1)
Platelet Activating Factor
280(1)
Summary
281(8)
Antimicrobial Agents
289(38)
Principles of Antimicrobial Therapy
289(16)
Identification of the Infecting Organism
290(1)
Stains and Cultures of Secretions
290(3)
Modes of Action of Antimicrobials
293(8)
Microbial Resistance
301(2)
Superinfections
303(1)
Routes of Administration of Antimicrobials
303(1)
Combination of Antibiotics
304(1)
Specific Classes of Antibiotics and Their Clinical Applications
305(18)
Antibacterial Agents
305(10)
Antiparasitic Agents
315(1)
Antituberculous Agents
316(3)
Antifungal Agents
319(1)
Antiviral Agents
320(3)
Summary
323(4)
New, Emerging, and Experimental Therapies
327(24)
New Therapies in Respiratory Care
327(12)
Pharmacologic Therapy of Pulmonary Hypertension
327(3)
Alpha1-Proteinase Inhibitor
330(4)
Surfactant Therapy
334(2)
Smoking Cessation Therapy
336(3)
Emerging and Experimental Therapies
339(12)
Expansion of Classes of Drugs
339(1)
Novel Therapies and Their Biologic Basis
340(11)
PART III CLINICAL PHARMACOLOGY AND APPLIED RESEARCH 351(90)
Respiratory Function: Assessing the Response to Therapy
353(42)
Definition and Description of Obstructive Airway Disease
354(5)
Asthma
354(1)
Chronic Bronchitis
355(1)
Emphysema
356(1)
Bronchiectasis
357(1)
Upper Airway Obstruction
358(1)
Hereditary Obstructive Lung Disease
359(1)
The Course of Airway Obstruction
359(2)
Interstitial Lung Disease
361(1)
Respiratory Symptoms
362(1)
Anatomic and Physiologic Considerations
363(5)
Flow in Tubes
363(1)
Reynolds Number
364(1)
Dimensions of the Tube
364(1)
Branching and Narrowing Points in Tubes
364(1)
Surface of the Tube
364(1)
Compliance of the Tube and Transbronchial Pressure
365(1)
Airway Anatomy
365(3)
Lung Function Tests
368(8)
Static Lung Volumes
368(1)
Dynamic Lung Volumes
368(4)
Relation Between Pressure and Flow
372(3)
Diffusing Capacity
375(1)
Nasal Function Tests
376(7)
Nasal Airflow
377(1)
Rhinomanometry
378(3)
Acoustic Rhinomanometry
381(1)
Peak Nasal Flow Rate
382(1)
Rhinoscopy
382(1)
Nasal Blood Flow
383(1)
Bronchial Provocation Testing
383(2)
Histamine and Methacholine
383(1)
Exercise and Cold
384(1)
Specific Airway Challenge
385(1)
Monitoring the Results of Therapy
385(5)
The Decompensated Patient
385(2)
The Stable Patient
387(2)
Interstitial Lung Disease
389(1)
Other Tests of Respiratory Function
390(5)
Airway Challenge Testing
395(22)
General Concepts and Utility
396(2)
Clinical Indications and Use of Testing
396(1)
Physiologic Basis for Hyperresponsiveness
396(2)
General Safety Considerations
398(1)
Factors That Influence the Response
398(1)
Methods of Testing
399(4)
Delivery of Aerosols that Provoke Bronchospasm
399(2)
Measurement of Response
401(1)
Analysis and Expression of Response
402(1)
Bronchial Challenge with Methacholine
403(1)
Chemistry
404(1)
Preparations
404(1)
Administration of the Test
404(1)
Airway Challenge with Other Agents
404(3)
Histamine and Other Mediators
404(1)
Exercise and Isocapnic Hyperventilation
405(1)
Nonisotonic Aerosols
406(1)
Challenge with Environmental Contaminants
406(1)
Other Methods of Provocation
407(10)
Provoking Cough
407(1)
Nasal Provocation
408(9)
Critical Care Pharmacology
417(24)
The Normal Cardiocirculatory System
418(3)
Preload
418(2)
Afterload
420(1)
Contractility
421(1)
Cardiocirculatory Failure
421(1)
Pulmonary Edema
422(1)
Cardiac Arrhythmias
423(5)
General Approach to the Care of the Patient in Cardiocirculatory Failure
428(1)
Specific Measures for Different States of Shock
429(1)
Hypovolemic Shock
429(1)
Cardiogenic Shock
429(1)
Septic Shock
429(1)
Pharmacologic Agents
430(11)
Preload Correction
430(2)
Afterload Reduction: Vasodilators
432(1)
Vasopressors and Inotropic Agents
433(3)
Pharmacologic Therapy for Cardiac Arrhythmia
436(5)
APPENDICES 441(4)
Medical Abbreviations Commonly Used in Respiratory Care
442(1)
Some Useful Equivalents
442(1)
Multiples and Submultiples of the Metric System
443(1)
Describing Solutions: Percentage Concentrations, Ratios, and Weight in Volume Equivalents
443(1)
Compendium of Respiratory Care Drugs Administered by Inhalation
444(1)
Index 445

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program